VOOZH about

URL: https://www.sanofi.com/en

⇱ R&D-Driven and AI-Powered Biopharmaceutical Company | Sanofi


We chase the miracles of science so you can chase your dreams.

Learn more

Our Latest Articles

Our Science

April 3, 2026

The Fast (And Intense) Lane: How Expedited Approvals Are Going Further and Faster for Patients

The Power of Chasing A Dream

Every day, we chase the miracles of science to improve people’s lives. We apply our deep understanding of the immune system to develop breakthrough innovations in medicines and vaccines so you can focus on what matters most, chasing your dreams. If you’re chasing your dreams, remember... you’re not alone. We’re right beside you

We are an R&D driven, AI-powered biopharmaceutical company committed to improving people’s lives and delivering compelling growth

About Us

Who We Are

We are an R&D driven,
AI-powered biopharma company committed to improving people’s lives and creating compelling growth.

Our Pipeline

5


Therapeutic areas

80


Compounds in clinical development

28


Clinical trials in phase 3

Pursue Progress. Discover Extraordinary. 

Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.

Our Latest Press Releases


March 31, 2026
Press Release: Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease

March 28, 2026
Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session

March 27, 2026
Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma

March 24, 2026
Press release: Availability of the Q1 2026 aide-mémoire